Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02403895
Title AZD2014 and Weekly Paclitaxel in Squamous NSCLC
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors AstraZeneca
Indications

lung squamous cell carcinoma

Therapies

Vistusertib

Paclitaxel

Age Groups: adult
Covered Countries USA | ESP | DEU


No variant requirements are available.